Dan Rudio

Dan Rudio has a diverse work experience spanning several companies. Dan is currently serving as the Chief Financial Officer at Nexstone Immunology since March 2022. Prior to this, they worked at CFGI as a Partner from April 2018 to March 2022.

Before this, Dan held various roles at Endo Pharmaceuticals from 2006 to 2018. These roles included positions such as SVP, Corporate Controller & Chief Accounting Officer from July 2016 to April 2018, VP, Controller from April 2011 to July 2016, Sr. Director, Finance & Accounting from March 2010 to April 2011, and Director, Financial Reporting from November 2006 to March 2010.

Earlier in their career, Dan worked at Rohm and Haas as a Finance Manager from 2004 to 2006 and as a Senior Technical Accounting Specialist from November 2002 to November 2004. Dan started their career at Ernst & Young LLP, where they worked as an Audit Manager from 1995 to 2002.

Dan Rudio earned a Bachelor of Science (BS) degree in Accounting & Finance from Rutgers University - Camden, where they studied from 1993 to 1996. Prior to that, they attended Lehigh University from 1991 to 1993, where they pursued engineering without completing a specific degree.